Homepage300261 • SHE
ABA Chemicals Corp
¥ 6,03
30 sep, 06:05:04 GMT+8 · CNY · SHE · Disclaimer
AandeelEffect wordt verhandeld in CN
Vorige slotkoers
¥ 5,65
Dag-range
¥ 5,72 - ¥ 6,12
Jaar-range
¥ 4,59 - ¥ 8,52
Beurswaarde
5,01 mld. CNY
Gem. volume
12,89 mln.
Koers/winst
-
Dividendrendement
-
Primaire beurs
SHE
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(CNY)jun 2024Wijziging j-o-j
Opbrengst
369,22 mln.-1,20%
Bedrijfskosten
64,51 mln.-27,75%
Netto inkomsten
-6,44 mln.-114,79%
Netto winstmarge
-1,74-114,94%
Winst per aandeel
EBITDA
25,72 mln.-63,06%
Effectief belastingtarief
32,52%
Totale activa
Totale passiva
(CNY)jun 2024Wijziging j-o-j
Contanten en kortetermijnbeleggingen
344,95 mln.-13,08%
Totale activa
4,17 mld.-0,48%
Totale passiva
1,77 mld.11,07%
Totaal aandelenvermogen
2,41 mld.
Uitstaande aandelen
963,31 mln.
Koers-boekwaardeverhouding
2,40
Rendement op activa
-0,52%
Rendement op kapitaal
-0,61%
Nettomutatie in liquide middelen
(CNY)jun 2024Wijziging j-o-j
Netto inkomsten
-6,44 mln.-114,79%
Operationele kasstroom
64,61 mln.3.212,80%
Kasstroom uit beleggingen
-25,60 mln.60,39%
Kasstroom uit financiering
-52,51 mln.25,88%
Nettomutatie in liquide middelen
-7,30 mln.93,38%
Vrije kasstroom
73,05 mln.219,33%
Over
ABA Chemicals, also known as Abachem, is a Chinese chemical manufacturing company headquartered in Taicang. The company was founded in 2006 as Suzhou ABA Chemicals, and is traded on the Shenzhen Stock Exchange as 300261. The company provides contract development and manufacturing services to the pharmaceutical, biotechnological, and agrochemical industries. It offers various services for the production of fine chemicals; intermediates; and active pharmaceutical ingredients. The company also provides unnatural amino acids, pyrazoles, triazoles, and azaindoles, as well as producing an intermediate of API Levetiracetam for the treatment of epilepsy. The company is also involved in pesticide manufacturing intermediates, and acquired the Chinese firm Shanghai Puyi Chemical to consolidate its position in this market. It also acquired Amino Chemicals, a pharmaceutical API intermediate manufacturer and member of the Dipharma Group, in 2017; Amino is based on Malta and was established in 1992. ABA and Dipharma began a working partnership in the 1980s, which provided Dipharma access to the Chinese pharmaceutical market. Wikipedia
Opgericht
13 jan 2006
Werknemers
1.218
Zoeken
Zoekopdracht wissen
Zoekfunctie sluiten
Google-apps
Hoofdmenu